|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Febuxostat,a novel nonpurine selective inhibitor of xanthine oxidase:a twenty-eight-day,multicenter,phase Ⅱ,randomized,double-blind,placebo-controlled,dose-response clinical trial examining safety and efficacy in patients with gout显示文摘 | Becker M A Schumacher H R Jr Wortmann R L | | 0，，03： | 1 |
| 2 | Generic bill-of-material: A new product model 显示文摘 | Hegge H M H Wortmann J C | 1991 | International Journal of Production Economics1991，23，13： | 1 |
| 3 | Gout therapeutics: new drugs for an old disease 显示文摘 | Burns C M Wortmann R L | 2011 | Lancet2011，377，9760： | 1 |
| 4 | Dementia: a global health priority--highlights from an ADI and World Health Organization report显示文摘 | Wortmann M | 2012 | Alzhei- mer'' s Res Ther2012，4，5： | 1 |
| 5 | Genetic bill-of-material:a new product model显示文摘 | Hegge H M H Wortmann J C | 1991 | International Journal of Production Economics1991，23，： | 1 |
| 6 | Febuxostat compared with allopurinol in patients with hyperuricemia and gout显示文摘 | Becker M A Schumacher H R Jr Wortmann R L | | 0，，23： | 1 |
| 7 | Generic Bill-of-material: A New Product Model显示文摘 | Wortmann J C | 1991 | International Journal of Production Economics1991，23，： | 1 |
| 8 | Dementia:a global health priority-highlights from an ADI and World Health Organization report显示文摘 | Wortmann M | 2012 | Alzheimers Res Ther2012，4，5： | 1 |
| 9 | Febuxostat compared with aUopurinol in patients with hyperurlcemia and gout 显示文摘 | BECKER M A SCHUMACHER H R Jr WORTMANN R L | 2005 | N Engl J IVied2005，353，23： | 1 |
| 10 | Generic bill-of-material:a new product model显示文摘 | HEGGE H M H WORTMANN J C | 1991 | International Journal of Production Economics1991，23，13： | 1 |
| 11 | Generic bill of material: A new production model 显示文摘 | Hegge H M H Wortmann J C | 1991 | International Journal of Production Economics1991，，23： | 1 |
| 12 | Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a 28-day, multicenter, phase Ⅱ, randomized, double-blind, placebo controlled dose-response clinical trial examining safety and efficacy in patients with gout 显示文摘 | BECKER M A SCHUMACHER H R Jr WORTMANN R L | 2005 | Arthritis Rheum2005，52，3： | 1 |
| 13 | Febuxostat compared with allopurinol in patients with hyperurice- mia and gout显示文摘 | BECKER M A SCHUMACHER HR J R WORTMANN R L | 2005 | N Engl J Meal2005，353，23： | 1 |
| 14 | Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase 显示文摘 | BECKER M A SCHUMACHER H R WORTMANN R L | 2005 | Arthritis & Rheumatism2005，52，3： | 1 |
| 15 | Clinical and diagnostic approach in unsolved CDG patients with a type 2 transferrin pattern显示文摘 | Mohamed M Guillard M Wortmann SB | | 0，，06： | 1 |
| 16 | Febuxostat compared with allopurinol in patients with hypemricemia and gout显示文摘 | BECKER M A SCHUMACHER H R WORTMANN R L | 2005 | N Engl J Med2005，353，23： | 1 |
| 17 | Phonon density of states of iron up to 153 Gigapascals显示文摘 | Mao H.K Xu J Struzhkin V.V Shu J.F Hemley R.J Sturhahn W Wu M.Y Alp E.E Vocadlo L Alfe D Price G.D Gillan M.J Schwoerer-B(o)hning M H(a)usermann D Eng P Shen G Giefers H Lubbers R Wortmann G | | 0，，： | 1 |
| 18 | Generic bill-of-material:a new product model 显示文摘 | HEGGE H M H WORTMANN J C | 1991 | International Journal of Production Economics1991，23，： | 1 |
| 19 | Multi-View Interaction Modelling of human collaboration processes: a business process study of head and neck cancer care in a Dutch academic hospital 显示文摘 | Stuit M Wortmann H Szirbik N | 2011 | J Biomed Inform2011，44，6： | 1 |
| 20 | Gout therapeutics: New drugs for an old disease显示文摘 | Burns C M Wortmann R L | 2011 | The Lancet2011，377，9760： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员